- Home
- KRMD vs FENC Comparison
KRMD vs FENC Comparison
Compare KRMD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- FENC
- Stock Information
- Founded
- KRMD 1980
- FENC 1996
- Country
- KRMD United States
- FENC United States
- Employees
- KRMD N/A
- FENC N/A
- Industry
- KRMD Medical/Dental Instruments
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KRMD Health Care
- FENC Health Care
- Exchange
- KRMD Nasdaq
- FENC Nasdaq
- Market Cap
- KRMD 187.5M
- FENC 156.9M
- IPO Year
- KRMD N/A
- FENC 2001
- Fundamental
- Price
- KRMD $4.12
- FENC $6.23
- Analyst Decision
- KRMD Strong Buy
- FENC Strong Buy
- Analyst Count
- KRMD 5
- FENC 2
- Target Price
- KRMD $4.50
- FENC $14.00
- AVG Volume (30 Days)
- KRMD 137.2K
- FENC 61.2K
- Earning Date
- KRMD 03-12-2025
- FENC 03-20-2025
- Dividend Yield
- KRMD N/A
- FENC N/A
- EPS Growth
- KRMD N/A
- FENC N/A
- EPS
- KRMD N/A
- FENC N/A
- Revenue
- KRMD $31,993,796.00
- FENC $49,348,000.00
- Revenue This Year
- KRMD $20.04
- FENC $170.43
- Revenue Next Year
- KRMD $14.15
- FENC $6.70
- P/E Ratio
- KRMD N/A
- FENC N/A
- Revenue Growth
- KRMD 11.57
- FENC 278.09
- 52 Week Low
- KRMD $1.98
- FENC $3.96
- 52 Week High
- KRMD $4.60
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- KRMD 58.45
- FENC 59.87
- Support Level
- KRMD $3.81
- FENC $5.45
- Resistance Level
- KRMD $4.21
- FENC $6.19
- Average True Range (ATR)
- KRMD 0.19
- FENC 0.29
- MACD
- KRMD -0.00
- FENC -0.01
- Stochastic Oscillator
- KRMD 64.83
- FENC 85.71
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.